A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis
Stopped early · Phase 1 · Has a placebo group
Conditions studied: Psoriasis
In brief
This study is being conducted to determine how safe and how well tolerated LY3462817 is when given to participants with psoriasis. Blood tests will be done to check how much LY3462817 is in the bloodstream and how long the body takes to get rid of it. The study will last up to one year and one month for each participant. As part of protocol addendum, this study is additionally evaluating the safety and tolerability of LY3509754 in participants with psoriasis. Blood tests will be done to check how much LY3509754 is in the bloodstream and how long the body takes to get rid of it. The addendum will last up to 12 weeks for each participant.
Key facts
- Study ID
- NCT04152382
- Run by
- Eli Lilly and Company
- People needed
- 30
- Starts
- 2019-11-20
- Expected to finish
- 2022-02-09
- Last updated by the study team
- 2022-03-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participants must have been diagnosed with psoriasis for at least 6 months
- Participants must have active psoriasis plaques
- Participants must be willing and able to have skin biopsies (small samples of skin removed for testing)
You may not qualify if…
- Participants must not have received certain medications for psoriasis that are applied to the skin within 14 days prior to baseline (Day 1)
- Participants must not have received certain oral or injectable medications or light therapy for psoriasis within 4 weeks prior to baseline
Where it is running
- Dermatology Associates - Los Angeles — Los Angeles, California, United States
- Miami Dermatology and Laser Research — Miami, Florida, United States
- Advanced Pharma Clinical Research — Miami, Florida, United States
- ForCare Clinical Research — Tampa, Florida, United States
- Avita Clinical Research — Tampa, Florida, United States
- Meridian Clinical Research — Baton Rouge, Louisiana, United States
- DermDox Centers for Dermatology — Hazleton, Pennsylvania, United States
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
- Progressive Clinical Research — San Antonio, Texas, United States
- Texas Dermatology and Laser Specialists — San Antonio, Texas, United States
- Simcoderm Medical & Surgical Dermatology Centre — Barrie, Ontario, Canada
- Skin Health — Cobourg, Ontario, Canada
- K. Papp Clinical Research — Waterloo, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.